IVIVA Medical is a company focused on organ engineering, led by Founder Harald Ott, MD. Their multidisciplinary approach combines stem cell and developmental biology, engineering, and medical expertise to create living therapeutics with advanced functions like gas exchange, blood filtration, and reabsorption. With two decades of research, IVIVA has achieved significant milestones in bioengineering organs such as hearts, lungs, kidneys, vasculature, myocardium, intestines, pancreas, and bioartificial human-scale organs. Their goal is to address organ shortage by developing biomimetic platforms and systems using tissue engineering, 3D additive manufacturing, and stem cell biology to provide innovative regenerative medicine solutions.